Clinical Trial Type: Lung

Name: GENMAB What type of cancer is this for? Non-small-cell lung cancer Phase: II Who is this trial for? Men and women who have non-small-cell lung cancer that has spread to other parts of their body. What biomarkers are involved? Your tumor must have PD-L1 expression in greater than 1% of your tumor cells. What